ABITEC

ABITEC unveils comprehensive custom lipid synthesis capabilities for LNP therapeutics

LNP developers now have access to bench-to-patient lipid synthesis support from a single partner 8 October 2024 - Columbus, OH, US - ABITEC Corporation, a global leader in specialty lipid manufacturing, has expanded its custom synthesis capabilities to include high-purity lipids for lipid nanoparticle (LNP) therapeutics. The comprehensive bench-to-patient service offering will address key market...